» Articles » PMID: 7543947

Alterations in Cerebral Cortical Galanin Concentrations Following Neurotransmitter-specific Subcortical Lesions in the Rat

Overview
Journal J Neurosci
Specialty Neurology
Date 1995 Aug 1
PMID 7543947
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Galanin is associated with multiple projection neurons, and its immunoreactivity in the cerebral cortex may be derived from diverse sources. We investigated the effects of subcortical lesions on cerebral cortical galanin concentrations. Lesions of the anterior noradrenergic bundle (ANB) comparably reduced cerebral cortical galanin and norepinephrine (NE) concentrations. The effects of the ANB lesions on galanin were immediate and became most pronounced 1 week later. Extensive unilateral lesions of the nucleus basalis of Meynert (NBM) decreased galanin concentrations, although not as markedly as after ANB lesions. The NBM lesions had no additional effect in the presence of an ANB lesion. Decreases in cerebral cortical galanin concentrations depended upon the extent and the duration of the NBM lesion and were not as pronounced as the decreases in markers of cholinergic activity. Acute treatments with physostigmine, which inhibit cerebral cortical AChE, had no effect on galanin concentrations. The depletion of galanin following an NBM lesion was most pronounced within hours of the insult, while the depletion of ChAT following the same lesions required several days to develop. Cortical concentrations of galanin and 5-HT increased 1 hr after dorsal raphe nucleus (DRN) lesions and then decreased 7 d later. Six weeks later, galanin concentrations recovered in the cerebral cortex despite the continued depletion of 5-HT. These studies suggest that a substantial portion of cerebral cortical galanin may derive from noradrenergic neurons and may be modulated by cortically-projecting ACh and 5-HT neurons.

Citing Articles

GABAergic terminals are a source of galanin to modulate cholinergic neuron development in the neonatal forebrain.

Keimpema E, Zheng K, Barde S, Berghuis P, Dobszay M, Schnell R Cereb Cortex. 2013; 24(12):3277-88.

PMID: 23897649 PMC: 4224245. DOI: 10.1093/cercor/bht192.


Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.

Elliott-Hunt C, Holmes F, Hartley D, Perez S, Mufson E, Wynick D J Alzheimers Dis. 2011; 25(3):455-62.

PMID: 21471641 PMC: 3145121. DOI: 10.3233/JAD-2011-110011.


Neuroprotective role for galanin in Alzheimer's disease.

Counts S, Perez S, Ginsberg S, Mufson E Exp Suppl. 2011; 102:143-62.

PMID: 21299067 PMC: 3117305. DOI: 10.1007/978-3-0346-0228-0_11.


A short estrogen-responsive N-terminal galanin homologue found in rat brain and gut with antiserum raised against rat galanin(1-16).

Hilke S, Hokfelt T, Theodorsson E Neurochem Res. 2006; 31(2):177-88.

PMID: 16586031 DOI: 10.1007/s11064-005-9007-5.


Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin.

Kokaia M, Holmberg K, Nanobashvili A, Xu Z, Kokaia Z, Lendahl U Proc Natl Acad Sci U S A. 2001; 98(24):14006-11.

PMID: 11698649 PMC: 61157. DOI: 10.1073/pnas.231496298.